Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids in Crohn's disease.

Yu-Xiao Yang1, Gary R Lichtenstein

  • 1Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA.

The American Journal of Gastroenterology
|May 11, 2002
PubMed
Summary

Corticosteroids effectively induce remission in Crohn's disease but do not maintain it long-term and have side effects. New therapies offer better management for this chronic inflammatory bowel disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Disease Entity of MetALD.

Gastroenterology & hepatology·2026
Same author

Therapeutic Approaches for Disorders of Gut-Brain Interaction Other Than Medication.

Gastroenterology & hepatology·2026
Same author

Update on the Management of Pregnant Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026
Same author

Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.

The American journal of gastroenterology·2026
Same author

Nutritional Management of Adult Patients Who Have Crohn's Disease.

Gastroenterology & hepatology·2026
Same author

The Evolving Concept of a Therapeutic Window of Opportunity for Crohn's Disease.

Gastroenterology & hepatology·2026

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Crohn's disease is a chronic inflammatory bowel disease with unknown etiology.
  • It involves heightened immune responses and intestinal inflammation mediated by cytokines.
  • Corticosteroids are a primary treatment for inducing remission.

Purpose of the Study:

  • To review the efficacy of corticosteroids in Crohn's disease treatment.
  • To explore alternative and biological therapies for managing Crohn's disease.

Main Methods:

  • Review of controlled trials (National Cooperative Crohn's Disease Study, European Cooperative Crohn's Disease Study).
  • Analysis of corticosteroid effectiveness for induction versus maintenance of remission.
  • Evaluation of side effects and dependence potential of corticosteroids.

Related Experiment Videos

  • Assessment of alternative and biological therapies.

    • Main Results:

    • Corticosteroids effectively induce remission in Crohn's disease within 6-17 weeks.
    • Corticosteroids do not demonstrate efficacy in maintaining long-term remission.
    • Corticosteroids are associated with significant dependence and toxic side effects.
    • Alternative therapies, including biological agents, show efficacy in managing active and quiescent Crohn's disease.

    Conclusions:

    • While corticosteroids are useful for short-term Crohn's disease remission induction, they are not suitable for long-term maintenance.
    • The development of alternative and biological therapies is crucial for effective Crohn's disease management.
    • Further research into novel treatments is warranted to address the limitations of current therapies.